Jivi.ai, a healthcare startup founded by former BharatPe chief product officer Ankur Jain and GVK family promoter Sanjay Reddy, has launched an artificial intelligence (AI)-powered risk assessment platform for human metapneumovirus (HMPV).
The venture counts Andrew Ng among its backers, with the deep-learning pioneer and co-founder of Google Brain serving as both investor and technical adviser.
The platform, which operates through smartphones, analyses user symptoms and vital parameters to evaluate HMPV risk levels. It utilises the phone’s front camera as a contactless heart rate monitoring system to derive the user’s vitals and couples this with a voice- or text-based interactive session to assess the risk levels. The app supports 14 languages, and is available free of charge to users worldwide.
“We’ve built this risk assessment tool to ensure preparedness in case the situation escalates into a possible pandemic. The first line of defence is providing accurate and timely information,” said Jain.
The company’s underlying technology, Jivi MedX, is a large language model trained on medical literature, research papers, and clinical notes. This model has recorded a 91.65% accuracy score across nine benchmark categories on the Open Medical LLM Leaderboard, surpassing similar offerings from Google and OpenAI. The startup maintains a significant medical presence in its workforce, with doctors comprising 40% of its team, including in-house surgeons and physicians who validate the platform’s outputs.
